Hospital admission patterns in adult patients with skin and soft tissue infections: Identification of potentially avoidable hospital admissions through a retrospective database analysis
- PMID: 26224423
- DOI: 10.1080/21548331.2015.1076325
Hospital admission patterns in adult patients with skin and soft tissue infections: Identification of potentially avoidable hospital admissions through a retrospective database analysis
Abstract
Background: Despite the substantial hospitalization costs associated with the management of patients with skin and soft tissue infections (SSTIs) in the inpatient setting, there is limited guidance on patients who should be managed in the hospital relative to the outpatient setting. Studies have demonstrated that SSTI patients without major complications or comorbidities can be successfully managed in the outpatient setting. However, there are limited data on current hospital admission patterns for patients with SSTI.
Objectives: Given this literature gap, this study described the current hospital admission patterns among adult patients with SSTI using data from a US hospital research database.
Methods: To determine the subset of hospitalized SSTI patients who could likely be managed in the outpatient setting (potentially avoidable hospital admissions), the distribution of hospital admissions was categorized by infection severity and Charlson Comorbidity Index (CCI) score.
Results: During the study observational period, there were 610,867 medical encounters across 520 hospitals. Of the 610,867, 125,743 (20.6%) were treated as inpatients. Nearly all patients with life-threatening conditions or systemic symptoms or a CCI score of 2 or greater were admitted. Among those with no life-threatening conditions and no systemic symptoms, admission rates exceeded 10 and 30% for patients with a CCI score of zero and 1, respectively. While the admissions rates for these patient populations were low, they accounted for nearly 60% of all admissions (75,255 of 125,743 hospital admissions). On average, patients with CCI score of zero or 1, independent of the presence of systemic symptoms, were treated in the hospital for about 4 days, costing $6000-$7000 on average.
Conclusions: Given the cost associated with the management of patients with SSTIs in the inpatient setting, the findings highlight the critical need for healthcare systems to develop well-defined criteria for hospital admission based on presence of comorbid conditions and infection severity.
Keywords: Bacterial infections; economics; infectious; medical; skin diseases; skin infection; staphylococcal.
Similar articles
-
Epidemiology, treatment, and economics of patients presenting to the emergency department for skin and soft tissue infections.Hosp Pract (1995). 2017 Feb;45(1):9-15. doi: 10.1080/21548331.2017.1279519. Epub 2017 Jan 16. Hosp Pract (1995). 2017. PMID: 28055287
-
Increasing national burden of hospitalizations for skin and soft tissue infections in children.J Pediatr Surg. 2011 Oct;46(10):1935-41. doi: 10.1016/j.jpedsurg.2011.05.008. J Pediatr Surg. 2011. PMID: 22008331
-
Skin and soft tissue infections in hospitalized and critically ill patients: a nationwide population-based study.BMC Infect Dis. 2010 Jun 4;10:151. doi: 10.1186/1471-2334-10-151. BMC Infect Dis. 2010. PMID: 20525332 Free PMC article.
-
Advances in the medical management of skin and soft tissue infections.BMJ. 2016 Dec 14;355:i6004. doi: 10.1136/bmj.i6004. BMJ. 2016. PMID: 27974335 Review.
-
Acinetobacter baumannii skin and soft-tissue infection associated with war trauma.Clin Infect Dis. 2008 Aug 15;47(4):444-9. doi: 10.1086/590568. Clin Infect Dis. 2008. PMID: 18611157 Review.
Cited by
-
Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials.Open Forum Infect Dis. 2017 Jan 19;4(1):ofw274. doi: 10.1093/ofid/ofw274. eCollection 2017 Winter. Open Forum Infect Dis. 2017. PMID: 28480266 Free PMC article.
-
Early Directed Oritavancin Therapy in the Emergency Department May Lead to Hospital Avoidance Compared to Standard Treatment for Acute Bacterial Skin and Skin Structure Infections: A Real-World Retrospective Analysis.Drugs Real World Outcomes. 2020 Jun;7(Suppl 1):20-29. doi: 10.1007/s40801-020-00201-y. Drugs Real World Outcomes. 2020. PMID: 32588384 Free PMC article.
-
The Real-World Economic and Clinical Management of Adult Patients with Skin and Soft Tissue Infections (SSTIs) with Oritavancin: Data from Two Multicenter Observational Cohort Studies.Drugs Real World Outcomes. 2020 Jun;7(Suppl 1):6-12. doi: 10.1007/s40801-020-00199-3. Drugs Real World Outcomes. 2020. PMID: 32588389 Free PMC article.
-
Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.PLoS One. 2021 Mar 18;16(3):e0248129. doi: 10.1371/journal.pone.0248129. eCollection 2021. PLoS One. 2021. PMID: 33735185 Free PMC article.
-
Finding the niche: An interprofessional approach to defining oritavancin use criteria in the emergency department.Am J Emerg Med. 2020 Feb;38(2):321-324. doi: 10.1016/j.ajem.2019.158442. Epub 2019 Sep 12. Am J Emerg Med. 2020. PMID: 31839519 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous